UK markets open in 1 hour 18 minutes
NIKKEI 225
38,233.86 +31.49 (+0.08%) HANG SENG
18,519.08 +205.22 (+1.12%) CRUDE OIL
79.39 +0.40 (+0.51%) GOLD FUTURES
2,325.50 +3.20 (+0.14%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,256.38 -932.48 (-1.86%)
Hepion Pharmaceuticals, Inc. (336.F)
Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
At close: 08:38AM CEST
Currency in
Valuation measures4
| Market cap (intra-day) | 8.30M |
| Enterprise value | -7.90M |
| Trailing P/E | 0.37 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.09 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.62 |
| 52-week change 3 | -40.20% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 16.1800 |
| 52-week low 3 | 9.2000 |
| 50-day moving average 3 | 9.2000 |
| 200-day moving average 3 | 9.2000 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 4.34M |
| Implied shares outstanding 6 | 4.24M |
| Float 8 | 4.99M |
| % held by insiders 1 | 0.31% |
| % held by institutions 1 | 13.66% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | N/A |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 11 May 2023 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -72.21% |
| Return on equity (ttm) | -171.26% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -45.19M |
| Net income avi to common (ttm) | -48.93M |
| Diluted EPS (ttm) | -12.2400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 14.79M |
| Total cash per share (mrq) | 2.7 |
| Total debt (mrq) | 209.02k |
| Total debt/equity (mrq) | 2.87% |
| Current ratio (mrq) | 3.31 |
| Book value per share (mrq) | 1.16 |
Cash flow statement
| Operating cash flow (ttm) | -40.89M |
| Levered free cash flow (ttm) | -25.88M |
© 2024 Yahoo. All rights reserved.